Mr. Rush (for himself, Mr. Waxman, Mr. Dingell, Mr. Doyle, Mr. Markey of Massachusetts, Mr. Stupak, Ms. Schakowsky, and Ms. DeGette) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
Henry A. Waxman
(CA); John D. Dingell
(MI); Michael F. Doyle
(PA); Edward J. Markey
(MA); Bart Stupak
(MI); Janice D. Schakowsky
(IL); Diana DeGette
(CO)
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Protecting Consumer Access to Generic Drugs Act of 2009. H.R. 1706. 111th
Cong., 1st
sess., Introduced in House March 25, 2009. https://www.govinfo.gov/app/details/BILLS-111hr1706ih.
APA
Congress, House of Representatives (2009, March 25). Protecting Consumer Access to Generic Drugs Act of 2009 (H.R. 1706 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-111hr1706ih.
MLA
United States, Congress, House of Representatives. Protecting Consumer Access to Generic Drugs Act of 2009. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-111hr1706ih. 111th Congress, H.R. 1706, Introduced in House 25 Mar. 2009.
Bluebook
H.R.1706 - 111th Congress (2009-2010): Protecting Consumer Access to Generic Drugs Act of 2009, H.R.1706, 111th Cong. (2009), https://www.govinfo.gov/app/details/BILLS-111hr1706ih.
